{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:05:15Z","timestamp":1776434715675,"version":"3.51.2"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/aco.0b013e3283556129","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T10:52:24Z","timestamp":1338979944000},"page":"419-427","source":"Crossref","is-referenced-by-count":55,"title":["Pharmacogenetics in perioperative medicine"],"prefix":"10.1097","volume":"25","author":[{"given":"Mindy","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilkumar","family":"Sadhasivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0009-9236(03)00053-5","article-title":"A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine.","volume":"73","author":"Sawyer","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.clpt.6100385","article-title":"Association of ABCB1MDR1 and OPRM1 gene polymorphisms with morphine pain relief.","volume":"83","author":"Campa","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-4-64","article-title":"Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.","volume":"4","author":"Rakvag","year":"2008","journal-title":"Mol Pain"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1213\/ANE.0b013e318202cc8d","article-title":"Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.","volume":"112","author":"Kolesnikov","year":"2011","journal-title":"Anesth Analg"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pain.2009.07.013","article-title":"Meta-analysis of the relevance of the OPRM1 118AG genetic variant for pain treatment.","volume":"146","author":"Walter","year":"2009","journal-title":"Pain"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-5-32","article-title":"Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for postoperative pain.","volume":"5","author":"Tan","year":"2009","journal-title":"Mol Pain"},{"key":"R7-5-20210129","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.","volume":"82","author":"Tateishi","year":"1996","journal-title":"Anesth Analg"},{"key":"R8-5-20210129","first-page":"932","article-title":"Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.","volume":"24","author":"Feierman","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.09.004","article-title":"Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.","volume":"147","author":"Fukuda","year":"2009","journal-title":"Pain"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2008.02.023","article-title":"Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women.","volume":"139","author":"Landau","year":"2008","journal-title":"Pain"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e318231fc11","article-title":"Pharmacological consequence of the A118G mu opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca(2) channels in humanized mouse sensory neurons.","volume":"115","author":"Mahmoud","year":"2011","journal-title":"Anesthesiology"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1744-8069-5-37","article-title":"Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid remifentanil in humans.","volume":"5","author":"Kosek","year":"2009","journal-title":"Mol Pain"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00498250310001657559","article-title":"Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone.","volume":"34","author":"Benetton","year":"2004","journal-title":"Xenobiotica"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.psy.44.2.167","article-title":"Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality. Part I.","volume":"44","author":"Armstrong","year":"2003","journal-title":"Psychosomatics"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2010.127","article-title":"OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.","volume":"88","author":"Bunten","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone-related deaths.","volume":"16","author":"Bunten","year":"2011","journal-title":"Addict Biol"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites.","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2125.2003.02002.x","article-title":"CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.","volume":"57","author":"Hutchinson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2011.287","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.","volume":"91","author":"Crews","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1213\/ane.0b013e31817b796e","article-title":"Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.","volume":"107","author":"Stamer","year":"2008","journal-title":"Anesth Analg"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00228-006-0191-2","article-title":"Effect of the CYP2D610 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.","volume":"62","author":"Wang","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(03)00212-4","article-title":"Impact of CYP2D6 genotype on postoperative tramadol analgesia.","volume":"105","author":"Stamer","year":"2003","journal-title":"Pain"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/BF00180294","article-title":"The metabolism of tramadol by human liver microsomes.","volume":"70","author":"Paar","year":"1992","journal-title":"Clin Investig"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0026-0495(03)00256-7","article-title":"A rapid and simple CYP2D6 genotyping assay: case study with the analgetic tramadol.","volume":"52","author":"Borlak","year":"2003","journal-title":"Metabolism"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0009-9236(96)90211-8","article-title":"The hypoalgesic effect of tramadol in relation to CYP2D6.","volume":"60","author":"Poulsen","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s002100000266","article-title":"Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor.","volume":"362","author":"Gillen","year":"2000","journal-title":"Naunyn Schmiedeberg Arch Pharmacol"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tox.2009.08.013","article-title":"Polymorphisms of human cytochrome P450 2C9 and the functional relevance.","volume":"278","author":"Zhou","year":"2010","journal-title":"Toxicology"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-2952(97)00143-3","article-title":"Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.","volume":"54","author":"Hamman","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mcp.2002.125726","article-title":"Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.","volume":"72","author":"Kirchheiner","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2125.2002.01660.x","article-title":"Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase.","volume":"54","author":"Sandberg","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clpt.2005.11.007","article-title":"Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C93.","volume":"79","author":"Lundblad","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.","volume":"5","author":"Brandt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.2011.132","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.","volume":"90","author":"Scott","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/138920009787846305","article-title":"Polymorphic drug metabolism in anaesthesia.","volume":"10","author":"Restrepo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000542-200408000-00006","article-title":"Anesthetic requirement is increased in redheads.","volume":"101","author":"Liem","year":"2004","journal-title":"Anesthesiology"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4097\/kjae.2008.55.2.139","article-title":"The influence of GABAA2 genetic polymorphism on the emergence agitation induced by sevoflurane.","volume":"55","author":"Park","year":"2008","journal-title":"Korean J Anesthesiol"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00000542-200101000-00021","article-title":"Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.","volume":"94","author":"Court","year":"2001","journal-title":"Anesthesiology"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.","volume":"10","author":"Mo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"R43-5-20210129","first-page":"24","article-title":"Pharmacology of benzodiazepine receptors: an update.","volume":"19","author":"Sieghart","year":"1994","journal-title":"J Psychiatry Neurosci"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clpt.2005.08.020","article-title":"CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.","volume":"78","author":"Inomata","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/cp.1999.v66.103379001","article-title":"Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects.","volume":"66","author":"Qin","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00008571-200310000-00003","article-title":"Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.","volume":"13","author":"Floyd","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000542-200503000-00011","article-title":"The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis A","volume":"102","author":"Candiotti","year":"2005","journal-title":"nesthesiology"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000542-200503000-00006","article-title":"Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads.","volume":"102","author":"Liem","year":"2005","journal-title":"Anesthesiology"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/clpt.2011.34","article-title":"Pharmacogenetics: from bench to byte - an update of guidelines.","volume":"89","author":"Swen","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/147323000803600624","article-title":"Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol.","volume":"36","author":"Yuan","year":"2008","journal-title":"J Int Med Res"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0009-9236(02)17734-4","article-title":"A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.","volume":"73","author":"Sofowora","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/17425255.4.1.77","article-title":"Role of pharmacogenetics in variable response to drugs: focus on opioids.","volume":"4","author":"Kadiev","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 10","key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/AJP.0b013e3181c49e11","article-title":"Clinical implications of opioid pharmacogenetics.","volume":"26","author":"Argoff","year":"2010","journal-title":"Clin J pain"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/AJP.0b013e31821d8ac1","article-title":"The metabolism of opioid agents and the clinical impact of their active metabolites.","volume":"27","author":"Smith","year":"2011","journal-title":"Clin J Pain"},{"key":"R55-5-20210129","first-page":"164","article-title":"Genetics: codeine metabolism.","volume":"55","author":"Gibbons","year":"2009","journal-title":"Can Fam Physician"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","article-title":"Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.","volume":"7","author":"Kirchheiner","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"R57-5-20210129","first-page":"33","article-title":"Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.","volume":"53","author":"Madadi","year":"2007","journal-title":"Can Fam Physician"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/clpt.2008.157","article-title":"Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.","volume":"85","author":"Madadi","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1634\/theoncologist.11-2-126","article-title":"Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.","volume":"11","author":"Bernard","year":"2006","journal-title":"Oncologist"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1460-9592.2011.03533.x","article-title":"Developmental pharmacogenomics.","volume":"21","author":"Neville","year":"2011","journal-title":"Paediatr Anaesth"},{"key":"R62-5-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/ALN.0b013e318178820b","article-title":"Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia.","volume":"109","author":"Nagele","year":"2008","journal-title":"Anesthesiology"},{"key":"R63-5-20210129","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1213\/ane.0b013e3181b493d4","article-title":"The association of malignant hyperthermia and unusual disease: when youre hot youre hot or maybe not.","volume":"109","author":"Davis","year":"2009","journal-title":"Anesth Analg"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"R65-5-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/14622416.8.7.743","article-title":"Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.","volume":"8","author":"Zanger","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1017\/S0265021507000476","article-title":"An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia.","volume":"24","author":"Iohom","year":"2007","journal-title":"Eur J Anaesthesiol"},{"key":"R67-5-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2125.2001.00344.x","article-title":"Involvement of human liver cytochrome P4502B6 in the metabolism of propofol.","volume":"51","author":"Oda","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2005.12.029","article-title":"Herbal monoterpene alcohols inhibit propofol metabolism and prolong anesthesia time.","volume":"79","author":"Li Lin","year":"2006","journal-title":"Life Sci"},{"key":"R69-5-20210129","first-page":"1442","article-title":"Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting Anesth A","volume":"109","author":"Rueffert","year":"2009","journal-title":"nalg"},{"issue":"Suppl 1","key":"R70-5-20210129","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jpain.2009.01.123","article-title":"The dopamine receptor 2 (DRD2) gene is associated with opioid-induced nausea and emesis.","volume":"10","author":"Ribeiro-Dasilva","year":"2009","journal-title":"J Pain"},{"key":"R71-5-20210129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ALN.0b013e31821810c7","article-title":"Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting.","volume":"115","author":"Janicki","year":"2011","journal-title":"Anesthesiology"},{"key":"R72-5-20210129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0922-4106(95)90072-1","article-title":"Cloning and characterization of the human GABAA receptor alpha 4 subunit: identification of a unique diazepam-insensitive binding site.","volume":"291","author":"Yang","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"R73-5-20210129","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1176\/ajp.156.9.1447","article-title":"Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity.","volume":"156","author":"Iwata","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R74-5-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1113\/jphysiol.2006.127027","article-title":"2nd, Waxman SG, et al. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.","volume":"581","author":"Sheets","year":"2007","journal-title":"J Physiol"},{"key":"R75-5-20210129","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.294.12.1526","article-title":"Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.","volume":"294","author":"Lanfear","year":"2005","journal-title":"JAMA"},{"key":"R76-5-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005082-200611000-00011","article-title":"Beta2-adrenergic receptor genotype predicts survival: implications and future directions.","volume":"21","author":"Lanfear","year":"2006","journal-title":"J Cardiovasc Nurs"},{"key":"R77-5-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijoa.2009.09.005","article-title":"Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and postcesarean delivery analgesia.","volume":"19","author":"Wong","year":"2010","journal-title":"Int J Obstetr Anesth"},{"key":"R78-5-20210129","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.clpt.2005.08.021","article-title":"Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.","volume":"78","author":"Landau","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R79-5-20210129","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1067\/mob.2002.128524","article-title":"beta2-Adrenergic receptor genotype and preterm delivery.","volume":"187","author":"Landau","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R80-5-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1515\/JPM.2004.138","article-title":"Beta2-adrenergic receptor gene polymorphisms and pregnancy outcome.","volume":"32","author":"Doh","year":"2004","journal-title":"J Perinat Med"},{"key":"R81-5-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.tpj.6500338","article-title":"Pharmacogenetics and the concept of individualized medicine.","volume":"6","author":"Shastry","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"R82-5-20210129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1542\/peds.2011-2607","article-title":"Unequal burden of perioperative pain and opioid related adverse effects in African-American and Caucasian children.","volume":"129","author":"Sadhasivam","year":"2012","journal-title":"Pediatrics"},{"key":"R85-5-20210129","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/17425255.2011.565051","article-title":"Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.","volume":"7","author":"Jannetto","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R86-5-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2010.279","article-title":"CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e3283556129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T03:17:20Z","timestamp":1687490240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201208000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e3283556129","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}